Colette Shen, MD
Radiation Oncology · Chapel Hill, NCNPI 1679830699
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,235 of the $5,749 with a category attached, or 91.1%. Janssen Scientific Affairs, LLC accounts for 80.1% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $5,375, more than ten times the $219 reported in 2023.
Across 8 payments — averaging $718.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$5K
- Johnson & Johnson$630
- Novocure Inc.$294
- Medtronic$191
- Ambu Inc.$28
Across 123 payments — averaging $37,859 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$4.6M
- GT Medical Technologies, Inc$48K
- Janssen Research & Development, LLC$33K
- Novocure GmbH$10K
- Novocure Inc.$96
What the payments were for
- Consulting fees$5,23591%
- Food & beverage$5149%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 3 | $4,605 |
| Johnson & Johnson | 1 | $630 |
| Novocure Inc. | 2 | $294 |
| Medtronic | 1 | $191 |
| Ambu Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,749 in reported general payments places this provider in the 85th percentile of 199 radiation oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 21 | $307 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Chapel Hill
- Andrew WangChapel Hill$118K
- Joel TepperChapel Hill$22K
- Brandon MullinsChapel Hill$8K
- Shivani SudChapel Hill$3K
- Dana CaseyChapel Hill$2K
- Ashley WeinerChapel Hill$2K
- Shekinah ElmoreChapel Hill$1K
- Volker StieberWinston Salem$99K
- Lewis SulmanDurham$54K
- Michael PapagikosWilmington$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.